lobbying_activities: 2503982

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2503982	12c11c87-aa4b-4691-95fb-80172ab11942	Q3	WATKINS & EAGER PLLC	401104403	ZYNERBA PHARMACEUTICALS, INC.	2020	third_quarter	PHA	Support Zynerba and its partners, and any other of its contractors in its process before the FDA; Troubleshoot inevitable issues and eligibility hurdles to ensure the project is considered for approval; Brief staff of FDA throughout process to ensure they have all information needed; Work with Zynerba to formulate the best strategy to work with FDA in preparation for any scheduled meetings.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2020-10-05T13:28:00.437000-04:00